AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.390
-0.050 (-3.47%)
At close: Mar 28, 2025, 4:00 PM
1.400
+0.010 (0.72%)
After-hours: Mar 28, 2025, 7:51 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $41.84 million as of March 28, 2025. Its market cap has decreased by -52.80% in one year.
Market Cap
41.84M
Enterprise Value
-41.78M
1-Year Change
-52.80%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $41.84M, a decrease of -85.12%. That is a compound annual growth rate of -46.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 41.84M | 1.47% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |